Valion Bio (VBIO) Q1 2026 Earnings Report

175 Followers

VBIO Q1 2026 EPS Results

Actual EPS-$53.77

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$62.96

Actual Revenue$0.00

Expected Revenue―

Beat/Miss―

YoY Revenue Growth-100.00%

QuarterQ1 2026

Date05/14/2026

TimeAfter Close

Conference CallThursday, May 14, 2026

VBIO Upcoming Earnings

Valion Bio's next earnings date is estimated for November 13, 2026, based on past reporting schedules.

VBIO Q1 2026 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 13, 2026	2026 (Q3)	- / -	-1.966	―
Aug 17, 2026	2026 (Q2)	- / -52.54	-54.778	4.09% (+2.24)
May 14, 2026	2026 (Q1)	- / -53.77	-62.964	14.60% (+9.20)
Mar 25, 2026	2025 (Q4)	- / -	-2.652	―
Nov 14, 2025	2025 (Q3)	- / -49.14	-97.75	49.73% (+48.61)
Aug 14, 2025	2025 (Q2)	- / -54.78	-136	59.72% (+81.22)
May 15, 2025	2025 (Q1)	- / -62.96	-429.25	85.33% (+366.29)
Mar 21, 2025	2024 (Q4)	- / -66.30	3859	-101.72% (-3925.30)
Nov 15, 2024	2024 (Q3)	- / -97.75	-629	84.46% (+531.25)
Aug 14, 2024	2024 (Q2)	- / -136.00	-2975	95.43% (+2839.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed